We Invest in the Bold to
Build the Healthcare Companies the World Needs Next.
At the convergence of biology and intelligence, we build Bio-AI companies redefining health for generations.
Transforming Science Into Enduring Value.
Healthcare’s future will be shaped at the intersection of biology and intelligence.
Panacea Capital exists to realise that future — by building, investing in, and scaling Bio-AI ventures with precision, conviction, and global ambition.
We understand the challenges of building from first principles — because we’ve lived them.
We stand alongside founders with
the insight of experience, the discipline of investors,
and the patience of true partners.
We are truly invested.
Conviction. Compounded.
Every Investment.
50+ Years
Science, Strategy & Scale
Entrepreneurs, operators, and investors across health and tech.
100%
Oversubscribed Rounds
Every round exceeded its target.
90%
Follow-On Success
Most raised again — with strong step-ups.
£200M+
Capital Channeled
Backed from first cheque to Series A and beyond.
AI Drug Rescue
AI Drug Rescue
AI Drug Rescue
AI Drug Rescue
AI Drug Rescue
AI Drug Rescue
Decoding Cardiovascular Biology
Decoding Cardiovascular Biology
Decoding Cardiovascular Biology
Decoding Cardiovascular Biology
Decoding Cardiovascular Biology
Decoding Cardiovascular Biology
Computational platform for undruggable diseases
Computational platform for undruggable diseases
Computational platform for undruggable diseases
Computational platform for undruggable diseases
Computational platform for undruggable diseases
Computational platform for undruggable diseases
Developing revolutionary mitochondrial-targeted therapeutics
Developing revolutionary mitochondrial-targeted therapeutics
Developing revolutionary mitochondrial-targeted therapeutics
Developing revolutionary mitochondrial-targeted therapeutics
Developing revolutionary mitochondrial-targeted therapeutics
Developing revolutionary mitochondrial-targeted therapeutics
AI-powered genomic analysis platform for precision medicine
AI-powered genomic analysis platform for precision medicine
AI-powered genomic analysis platform for precision medicine
AI-powered genomic analysis platform for precision medicine
AI-powered genomic analysis platform for precision medicine
AI-powered genomic analysis platform for precision medicine
.png)
CardiaTec
CardiaTec is a TechBio company leveraging large scale multiomics data to discover novel cardiovascular therapeutics. Spun out of the Han Lab, University of Cambridge, CardiaTec is building the largest human cardiac tissue multiomic database with first targets ready for pre-clinical validation.
OutSee
AI-powered genomic analysis platform for precision medicine
MitoRx Therapeutics
Developing revolutionary mitochondrial-targeted therapeutics
Axiom Therapeutics
Computational platform for undruggable diseases
%20(1).png)
Ignota Labs
Ignota Labs rescues promising drugs from failure, through a proprietary AI model, SAFEPATH, applying deep learning to combined bioinformatics and cheminformatics datasets to solve drug safety issues. Bringing new life to abandoned projects and new hope to patients.
Venture Realisation,
Redefined.
Origins of Excellence
Sourced from world-leading research, focused on breakthroughs with global relevance.
De-risked with Expertise
Every investment sharpened through technical, commercial, and regulatory validation.
Built by SciBiz Experts
A team fluent in both science and business, translating potential into enduring companies.
Engineered for Global Scale
Strategic access to capital, corporates, and markets — from inception to expansion.